EUVIMEDEUVIMED entdecken
Crossref

Two cases of pyoderma gangrenosum treated successfully with Adalimumab supported by systemic management and infection control

Yuki Toba, Tsuyoshi Inoue, Hiroo Amano

Journal of the Japan Organization of Clinical Dermatologists · 2026 · 43 (1) · 30-36

DOI: 10.3812/jocd.43.30 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Japan Organization of Clinical Dermatologists, 2026. Verfasst von Yuki Toba und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report two cases of pyoderma gangrenosum for which Adalimumab was administered in combination with infection control, leading to improvement of the overall condition and a favorable outcome. Case 1 had underlying rheumatoid arthritis and steroid-induced diabetes, while case 2 had underlying ulcerative colitis. In both cases, wound management was performed using Wound Cloth® and Prontosan®, and intervention was also performed for hypoalbuminemia, electrolyte abnormalities, and poor blood sugar control. This resulted in shrinkage of the ulcers, and epithelialization was achieved. Our experience of these cases suggests that systemic management and infection control in combination with Adalimumab administration is an effective approach for pyoderma gangrenosum.

Zitieren

APA

Toba, Y., Inoue, T., & Amano, H. (2026). Two cases of pyoderma gangrenosum treated successfully with Adalimumab supported by systemic management and infection control. Journal of the Japan Organization of Clinical Dermatologists, 43(1), 30-36. https://doi.org/10.3812/jocd.43.30

Vancouver

Toba Y, Inoue T, Amano H. Two cases of pyoderma gangrenosum treated successfully with Adalimumab supported by systemic management and infection control. Journal of the Japan Organization of Clinical Dermatologists. 2026;43(1):30-36. doi:10.3812/jocd.43.30

BibTeX
@article{Toba2026,
  author = {Toba, Yuki and Inoue, Tsuyoshi and Amano, Hiroo},
  title = {Two cases of pyoderma gangrenosum treated successfully with Adalimumab supported by systemic management and infection control},
  journal = {Journal of the Japan Organization of Clinical Dermatologists},
  year = {2026},
  volume = {43},
  number = {1},
  pages = {30--36},
  doi = {10.3812/jocd.43.30}
}
Kostenlos starten →